JNK pathway inhibition selectively primes pancreatic cancer stem cells to TRAIL-induced apoptosis without affecting the physiology of normal tissue resident stem cells

OBJECTIVE: Successful treatment of solid cancers mandates targeting cancer stem cells (CSC) without impact on the physiology of normal tissue resident stem cells. C-Jun N-terminal kinase (JNK) signaling has been shown to be of importance in cancer. We test whether JNK inhibition would sensitize panc...

Descripción completa

Detalles Bibliográficos
Autores principales: Recio-Boiles, Alejandro, Ilmer, Matthias, Rhea, P. Robyn, Kettlun, Claudia, Heinemann, Mitja L., Ruetering, Jennifer, Vykoukal, Jody, Alt, Eckhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891091/
https://www.ncbi.nlm.nih.gov/pubmed/26840266
http://dx.doi.org/10.18632/oncotarget.7066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891091/
https://www.ncbi.nlm.nih.gov/pubmed/26840266
http://dx.doi.org/10.18632/oncotarget.7066

Ejemplares similares